Table 3.

Percentage of total monitoring time during a 1-week longitudinal panel study with complete data for continuous sensors (spirometry and medications are summarized differently), including periods of sleep

Device/sensor25%50% Median75%100% Max
AirBeam13.7%22.2%36.2%83.3%
Accelerometer (smartwatch)19.5%40.2%50.4%75.2%
Gyroscope (smartwatch)24.5%45.4%55.4%75.3%
Heart rate (smartwatch)6.5%16.4%32.4%63.0%
Device/sensor25%50% Median75%100% Max
AirBeam13.7%22.2%36.2%83.3%
Accelerometer (smartwatch)19.5%40.2%50.4%75.2%
Gyroscope (smartwatch)24.5%45.4%55.4%75.3%
Heart rate (smartwatch)6.5%16.4%32.4%63.0%
Table 3.

Percentage of total monitoring time during a 1-week longitudinal panel study with complete data for continuous sensors (spirometry and medications are summarized differently), including periods of sleep

Device/sensor25%50% Median75%100% Max
AirBeam13.7%22.2%36.2%83.3%
Accelerometer (smartwatch)19.5%40.2%50.4%75.2%
Gyroscope (smartwatch)24.5%45.4%55.4%75.3%
Heart rate (smartwatch)6.5%16.4%32.4%63.0%
Device/sensor25%50% Median75%100% Max
AirBeam13.7%22.2%36.2%83.3%
Accelerometer (smartwatch)19.5%40.2%50.4%75.2%
Gyroscope (smartwatch)24.5%45.4%55.4%75.3%
Heart rate (smartwatch)6.5%16.4%32.4%63.0%
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close